Protective role of melatonin in liver damage. 2014

Cezary Chojnacki, and Ewa Walecka-Kapica, and Marek Romanowski, and Jan Chojnacki, and Grazyna Klupinska

The liver plays a key role in the detoxification of numerous molecules which results in the formation of an excessive number of toxic reactive oxygen species. This results in oxidative damage to the hepatocytes, which when severe, compromises the function of this critical organ. A variety of antioxidants protect the liver from free radical-mediated damage, one of the best of which is melatonin. Clinical studies have confirmed the melatonin, as well as it precursor tryptophan, protect the liver from non-alcoholic liver disease and also during the surgical procedure of partial liver resection.

UI MeSH Term Description Entries
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen

Related Publications

Cezary Chojnacki, and Ewa Walecka-Kapica, and Marek Romanowski, and Jan Chojnacki, and Grazyna Klupinska
November 2013, Toxicology and industrial health,
Cezary Chojnacki, and Ewa Walecka-Kapica, and Marek Romanowski, and Jan Chojnacki, and Grazyna Klupinska
August 2005, Pediatrics international : official journal of the Japan Pediatric Society,
Cezary Chojnacki, and Ewa Walecka-Kapica, and Marek Romanowski, and Jan Chojnacki, and Grazyna Klupinska
December 2023, Canadian journal of physiology and pharmacology,
Cezary Chojnacki, and Ewa Walecka-Kapica, and Marek Romanowski, and Jan Chojnacki, and Grazyna Klupinska
October 2011, Human & experimental toxicology,
Cezary Chojnacki, and Ewa Walecka-Kapica, and Marek Romanowski, and Jan Chojnacki, and Grazyna Klupinska
November 2019, Journal of cellular and molecular medicine,
Cezary Chojnacki, and Ewa Walecka-Kapica, and Marek Romanowski, and Jan Chojnacki, and Grazyna Klupinska
January 2004, Journal of applied toxicology : JAT,
Cezary Chojnacki, and Ewa Walecka-Kapica, and Marek Romanowski, and Jan Chojnacki, and Grazyna Klupinska
June 2022, Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES,
Cezary Chojnacki, and Ewa Walecka-Kapica, and Marek Romanowski, and Jan Chojnacki, and Grazyna Klupinska
August 2005, International immunopharmacology,
Cezary Chojnacki, and Ewa Walecka-Kapica, and Marek Romanowski, and Jan Chojnacki, and Grazyna Klupinska
January 2013, Oxidative medicine and cellular longevity,
Cezary Chojnacki, and Ewa Walecka-Kapica, and Marek Romanowski, and Jan Chojnacki, and Grazyna Klupinska
January 2010, Digestive diseases (Basel, Switzerland),
Copied contents to your clipboard!